Brain+ A/S's latest marketcap:
As of 07/26/2025, Brain+ A/S's market capitalization has reached $2.82 M. According to our data, Brain+ A/S is the 45680th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.82 M |
| Revenue (ttm) | 1.24 M |
| Net Income (ttm) | -1,895,064.98 |
| Shares Out | 1.13 B |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/28/2025 |
Brain+ A/S's yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/26/2025 | kr17.9 M | $2.82 M | -10.21% | 45680 |
| 12/30/2024 | kr19.94 M | $2.76 M | 56.98% | 42577 |
| 12/29/2023 | kr12.7 M | $1.88 M | -37.15% | 41834 |
| 12/30/2022 | kr20.21 M | $2.9 M | -50% | 39583 |
| 12/30/2021 | kr40.41 M | $6.18 M | 36928 |
Company Profile
About Brain+ A/S
Brain+ A/S is a pioneering company specializing in the development of digital therapeutics for Alzheimer’s and dementia. Founded in 2012 and headquartered in Copenhagen, Denmark, the company focuses on innovative health tech solutions to improve cognitive care.
Key Products & Solutions
- CST-Assistant: A scalable health tech solution that supports group Cognitive Stimulation Therapy (CST) by simplifying preparation, adapting content, and standardizing delivery—reducing reliance on therapist performance.
- CST - Home Care: Extends CST to home settings, making therapy more accessible and affordable for dementia patients.
- CST/Computerized Cognitive Training (CCT) Combination: Designed for individuals with mild cognitive impairment, this product merges CST with CCT to enhance cognitive function and potentially delay dementia progression.
- Starry Night: A software-based test that detects early signs of cognitive decline, enabling timely intervention and treatment.
Brain+ A/S is committed to leveraging technology to enhance dementia care, offering scalable and cost-effective solutions for patients and healthcare providers.
Frequently Asked Questions
-
What is Brain+ A/S's (CPH-BRAINP) current market cap?As of 07/26/2025, Brain+ A/S (including the parent company, if applicable) has an estimated market capitalization of $2.82 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Brain+ A/S (CPH-BRAINP) rank globally by market cap?Brain+ A/S global market capitalization ranking is approximately 45680 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.